Alexandrou, S., Lee, C. S., Fernandez, K. J., Wiharja, C. E., Eshraghi, L., Reeves, J., . . . Caldon, C. E. JNK pathway suppression mediates insensitivity to combination endocrine therapy and CDK4/6 inhibition in ER+ breast cancer. BMC.
Chicago Style (17th ed.) CitationAlexandrou, Sarah, et al. JNK Pathway Suppression Mediates Insensitivity to Combination Endocrine Therapy and CDK4/6 Inhibition in ER+ Breast Cancer. BMC.
MLA (9th ed.) CitationAlexandrou, Sarah, et al. JNK Pathway Suppression Mediates Insensitivity to Combination Endocrine Therapy and CDK4/6 Inhibition in ER+ Breast Cancer. BMC.
Warning: These citations may not always be 100% accurate.